Researchers report experimental drug may prolong survival in ALS patients
Trial drug combination shows potential to prolong survival of ALS patients by more than six months.
Trial drug combination shows potential to prolong survival of ALS patients by more than six months.
UF was the No. 2 enroller of patients for multisite ALS trial.